{"product_id":"xultophy-pluma-3-6mg-ml-3ml-con-3-insulina-degludec-liraglutida","title":"Xultophy Pen 3.6Mg\/Ml 3Ml With 3 (Insulin Degludec\/Liraglutide)","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eMedicine\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eXultophy\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eNovo Nordisk\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eInsulin Degludec \/ Liraglutide\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e3.6 mg\/ml, 3 ml Pen\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eNovo Nordisk\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eXultophy is indicated for the treatment of adults with type 2 diabetes, as an adjunct to diet and exercise, when glycemic control is not adequately achieved with metformin alone or with metformin and other oral antidiabetic agents. This medication combines two antidiabetic agents: insulin degludec, a long-acting insulin analog, and liraglutide, a GLP-1 agonist. Its use is indicated in patients who require intensified treatment for the maintenance of blood glucose levels.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach ml of solution contains 3.6 mg of insulin degludec and 1.2 mg of liraglutide. Excipients include water for injection, sodium chloride, hydrochloric acid, and sodium hydroxide.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eThis medication is contraindicated in patients with hypersensitivity to insulin degludec, liraglutide, or any of the excipients. It is also contraindicated in patients with type 1 diabetes and in those with diabetic ketoacidosis. Its use is not recommended in individuals with a history of acute pancreatitis.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003ePrecautions should be taken in patients with kidney or liver diseases, as well as in those with a history of pancreatitis. It is important to monitor for the occurrence of hypoglycemia and adjust doses according to the patient's needs. Cardiac function should also be evaluated in patients with a history of heart disease, due to the potential effects of liraglutide.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore refrigerated between 2 °C and 8 °C. Do not freeze. Once opened, the product can be stored at room temperature (below 30 °C) and must be used within 21 days.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Novo Nordisk","offers":[{"title":"Default Title","offer_id":45849275498721,"sku":"7503007822888","price":4153.16,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/7503007822888.jpg?v=1744696848","url":"https:\/\/wecarepharma.mx\/en\/products\/xultophy-pluma-3-6mg-ml-3ml-con-3-insulina-degludec-liraglutida","provider":"WeCare Pharma","version":"1.0","type":"link"}